NCT00872963View on ClinicalTrials.gov

An Extended Follow up of a RTS,S/AS01E Malaria Vaccine Trial

UnknownOBSERVATIONAL
Enrollment

450

Participants

Timeline

Start Date

February 28, 2009

Primary Completion Date

February 29, 2016

Study Completion Date

August 31, 2016

Conditions
Malaria
Interventions
BIOLOGICAL

RTS,S/AS01E

0.5MLS of RTS,S/AS01E at 0,1,2 monthly schedule 0.5mls Rabies vaccine at 0,1,2 monthly schedule

Trial Locations (1)

80108

Kemri Wellcome Trust Research Programme, Kilifi

Sponsors

Collaborators (1)

GlaxoSmithKline
All Listed Sponsors
collaborator

GlaxoSmithKline

INDUSTRY

lead

KEMRI-Wellcome Trust Collaborative Research Program

OTHER

NCT00872963 - An Extended Follow up of a RTS,S/AS01E Malaria Vaccine Trial | Biotech Hunter | Biotech Hunter